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Abstract
The cellular form of the prion protein (PrPC) is a sialoglycoprotein widely expressed in the central nervous system (CNS) of
mammalian species during neurodevelopment and in adulthood. The location of the protein in the CNS may play a role in
the susceptibility of a species to fatal prion diseases, which are also known as the transmissible spongiform
encephalopathies (TSEs). To date, little is known about PrPC distribution in marsupial mammals, for which no naturally
occurring prion diseases have been reported. To extend our understanding of varying PrPC expression profiles in different
mammals we carried out a detailed expression analysis of PrPC distribution along the neurodevelopment of the metatherian
South American short-tailed opossum (Monodelphis domestica). We detected lower levels of PrPC in white matter fiber
bundles of opossum CNS compared to mouse CNS. This result is consistent with a possible role for PrPC in the distinct
neurodevelopment and neurocircuitry found in marsupials compared to other mammalian species.
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Introduction
The cellular form of the prion protein (PrPC) is a cell-surface
glycosylphosphatidylinositol-anchored glycopolypeptide abun-
dantly expressed in the central nervous system (CNS), with
expression levels varying among different cell types and brain
regions [1]. The distribution pattern of PrPC has already been
investigated in deep detail in the CNS of several placental
mammalian organisms, including mouse (Mo) [2–6], hamster [7],
cattle [8], sheep [9] and primates [10,11]. Additional studies,
along the same lines of research, have reported the pattern of PrPC
distribution also in avian [12] and fish [13]. The earliest expression
of the protein in mammals has been observed in the hippocampus,
thalamus and hypothalamus and the highest levels of PrPC
expression have been noted in specific white matter fiber tracts [6].
Structurally, mature PrPC expressed by a wide variety of
mammalian species shares a similar fold: while the N-terminus is
largely unstructured, the C-terminus possesses well-defined
secondary and tertiary structures [14,15]. The N-terminus features
an evolutionarily conserved motif denoted as the octapeptide-
repeat region (residues from 51 to 90 in Mo numbering, Figure 1).
The octapeptide-repeat region is able to coordinate the binding of
copper ions, thus implicating a possible role of PrPC in copper
homeostasis [16].
The sequence identity of PrPC among mammals suggests an
important physiological role [17]. However, the function of the
protein has not been fully clarified, mostly due to the fact that
PrPC-null mice (Prnp0/0) do not show remarkable phenotypic
abnormalities [18,19]. Putative PrPC functions are based on its
localization. In particular, the highest expression of the protein in
the hippocampus and, within this brain region, in the stratum
lacunosum-moleculare, suggests a role for PrPC in synaptic structure,
function and maintenance [6]. Additionally, the large number of
PrPC-interacting molecules identified thus far [20] implies that
PrPC may be a dynamic cell surface platform for the assembly of
signaling modules.
Defining the function of PrPC is also a prerequisite for
understanding TSEs, or prion diseases, as they are attributed to
the posttranslational conversion of PrPC into a misfolded,
pathogenic form denoted prion or PrPSc [21]. This group of rare
neurodegenerative maladies, affecting humans and animals alike,
can be sporadic, genetic or iatrogenic. They include Creutzfeldt-
Jakob disease (CJD), fatal familial insomnia and Gerstmann-
Stra¨ussler-Scheinker syndrome in humans, scrapie in sheep and
goats, bovine spongiform encephalopathy in cattle, and chronic
wasting disease in cervids.
A still controversial aspect in TSEs is the different ability of
prions to infect some mammalian species and not others. So far no
naturally occurring TSEs have been reported in rabbit, horse or
any marsupial species. A possible explanation for this argues that
the PrPC primary sequence, together with local structural
variations within the C-terminus globular domain, might account
for prion resistance in different mammals [22]. However, little is
known about the regional distribution of PrPC in the CNS of
mammalian species that seem resistant to TSEs. Differences in
PrPC expression in mammalian species, for which no naturally
occurring TSEs occur, may shed light on different susceptibility to
these maladies.
To gain insights into this neglected issue we analyzed PrPC
distribution along the neurodevelopment of the metatherian
mammal South American short-tailed opossum (Monodelphis
domestica) (hereafter Op). This animal model is used in develop-
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mental studies mainly because of the rudimental stage of
development of the newborn pups, which resemble 11- or 12-
day Mo embryos [23,24]. In the newborn Op pup the CNS is still
at an embryonic stage [23], because its development is completed
during postnatal life.
The Op genome sequencing has provided an important tool for
comparison with Eutherians, such as human and Mo, and has
contributed to our knowledge about the evolution of Amniota
[25,26]. Because of its evolutionary position between avian and
eutherian genomes, Op represents an invaluable model for
evolutionary comparison. Ultimately, its small size, ease of care
and the non-seasonal breeding make Op a suitable laboratory
animal model [27,28].
The assignment and characterization of Op prion protein (PrP)
gene has revealed that OpPrP and MoPrP share approximately
70% sequence identity [29]. Sequence variations are most
prominently localized on the N-terminus copper binding sites
region: while MoPrP contains one nonapeptide, and four
octarepeats of identical sequence, OpPrP features five different
decarepeats, which are able to bind copper ions [30,31].
Additionally, the region from residue 91 to 110 (in MoPrP
numbering), which also binds copper, is less conserved in OpPrP
(Figure 1).
In this work, the expression profile of OpPrP was characterized
at different postnatal developmental stages of Op CNS using
Western blotting and histoblot techniques. To compare OpPrP
and MoPrP distribution in CNS, we examined the expression of
PrPC in postnatal 30-day-old (P30) mice – which resemble young
adult Op in the overall development – under the same
experimental conditions.
The most striking difference between the two mammals
concerned the lower PrPC detection in the Op white matter
structures. The different organization pattern observed might offer
insights into the role of PrPC in neurodevelopment and in
neurocircuitry formation in Op and other mammals [32].




All experiments were carried out in accordance with European
regulations [European Community Council Directive, November
24, 1986 (86/609/EEC)] and were approved by the local
veterinary service authority. FVB wild-type, and FVB Prnp0/0
mice [33] were used in these experiments. Animals were obtained
from the colony maintained at the animal house facility of the
University of Trieste, Italy. Animals were staged by systematic
daily inspection of the colony for newborn litters. P0 corresponds
to the day of birth [34]. Each experiment was performed at least in
triplicate. Mice and Op pups were decapitated. Mice (at P30) and
Op adults (at P45, P50, and P75) were killed by cervical
dislocation. For histoblotting, brains were rapidly harvested,
immediately covered in powdered dry ice and included in the
embedding medium OCT (Optimal Cutting Temperature).
Histology
CNS specimens were fixed in 4% paraformaldehyde-PBS
overnight at 4uC, cryoprotected in 30% sucrose/PBS and cut
coronally at 20 mm. Cryosections were mounted on Fischer
SuperFrost Plus slides and subsequently processed for histology.
Figure 1. Comparison of amino acid sequences and secondary full-length prion protein structure of selected mammalian species:
mouse (MoPrP; Mus musculus, GenBank accession number: AAA39997), human (HuPrP; Homo sapiens, AAA60182), Syrian hamster
(ShPrP; Mesocricetus auratus, AAA37091), sheep (OvPrP; Ovis aries, ABC61639), elk (ElPrP; Cervus elaphus nelsoni, AAB94788), bank
vole (BvPrP; Clethrionomys glareolus, AAL57231), horse (EcPrP; Equus caballus, ABL86003), rabbit (RaPrP; Oryctolagus cuniculus,
AAD01554), tammar wallaby (TwPrP; Macropus eugenii, AAT68002) and opossum (OpPrP; Monodelphis domestica, CBY05848).
doi:10.1371/journal.pone.0050370.g001
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Histoblots
The histoblot technique was performed according to the
protocol described by Taraboulos et al. [35] with a few
modifications. Briefly, uncoated microscope slides (Menzel-Glaser,
Madison, WI) carrying 20 mm-thick brain serial coronal sections
were pressed onto a nitrocellulose membrane wetted in lysis buffer
(0.5% sodium deoxycholate, 0.5% Nonidet P-40, 100 mM NaCl,
10 mM EDTA, 10 mM Tris-HCl, pH 8.0), incubated for one
hour at room temperature in 0.1 M NaOH and rinsed 3 times for
1 minute in TBST 1X (50 mM Tris-HCl, 150 mM NaCl, 0.1%
Tween20, pH 7.4). Blots were blocked for 90 minutes in 5% non-
fat dry milk-TBST 1X. They were incubated overnight at 4uC
with the primary antibody anti-PrPC humanized Fab D18 [36]
purchased from InPro Biotechnology (South San Francisco, CA;
ABR-0D18) and used at a final concentration of 1 mg/mL. This
antibody shows high affinity for the region encompassing residues
133 to 152 (in Mo numbering), which is highly conserved in
different mammals (Figure 1). Membranes were extensively
washed in TBST 1X and incubated for one hour with secondary
antibody diluted in blocking mix. The signal was achieved using
SIGMAFASTTM 3,39-Diaminobenzidine tablets (Sigma) accord-
ing to the protocols of the supplier. All data are representative of at
least three independent experiments.
Nissl staining
Twenty-micrometer fixed frozen cryostat sections, mounted on
slides, were air-dried for 60 minutes, stained in 0.1% cressyl violet
(Sigma) at 40uC for 7 minutes and then rinsed in distilled water.
Slides were soaked in 95% ethyl alcohol for 5 minutes and
dehydrated in 100% alcohol for 5 minutes. Before mounting on
glass slides (Sigma) with resin medium (Eukitt, Bio-Optica) slides
were cleared twice in xylene for 5 minutes.
Western blotting analysis
Total brains or different brain regions were dissected using a
stereomicroscope (Nikon SMZ 800) and immediately frozen in
liquid nitrogen. Tissues were homogenized in RIPA buffer
(150 mM NaCl, NP-40 1%, sodium deoxycholate 0.5%, SDS
0.1%, 50 mM Tris, pH 8.0) with Glass/Teflon Potter Elvehjem
homogenizers and spun at 1000 g at 4uC for 5 minutes. The total
protein amount was determined using the BCA Protein Assay Kit
(Thermo Scientific Pierce). Fifty mg of total protein was then
electrophoresed through 10%–SDS polyacrylamide gels and
transferred to nitrocellulose membranes. Membranes were probed
with monoclonal antibody Fab D18 and developed by enhanced
chemiluminescence (Amersham ECL Western Blotting Systems,
GE Healthcare). Band intensity was quantified using the UVI Soft
software (UVITEC, Cambridge).
Results
PrPC expression in the Op brain is developmentally
regulated
PrPC protein extracts from adult knockout PrP (MoPrP2/2),
wild-type PrP (MoPrP+/+) mice and adult Op were compared
using Western blotting (Figure 2A). The expected di- (,37 kDa),
mono- (,30 kDa) and un- (,27 kDa) glycosylated forms were
detected by Fab D18 monoclonal antibody both in MoPrP+/+ and
Op lanes. The absence of signal in the lane loaded with MoPrP2/2
sample showed the specificity of the antibody. Although all the lanes
were loaded with the same amount of total protein, the lower
intensity of Op PrP signal compared to MoPrP+/+ signal might be
due to a lower affinity of the antibody for the Op PrP than for
MoPrP+/+. Alternatively, these results might indicate a lower PrPC
expression in adult Op than in Mo. Figure 2B shows the PrPC
pattern observed by immunoblotting from P1 to P45. A predom-
inance of the diglycosylated form of the protein at ,37 kDa and of
the monoglycosylated form of the protein at ,30 kDa was
observed. A minor band corresponding to the non-glycosylated
form of the protein was detected at ,27 kDa. This expression
pattern resembles those observed in eutherian Syrian hamster (SHa)
and Mo brains [37].
The PrPC expression from P10 to P70 was also evaluated in the
thalamus, olfactory bulbs, cortex and hippocampus (Figure 2C). In
all these regions an increase in PrPC expression was observed until
P50. In adulthood the expression of PrPC decreased slightly or
remained at plateau. Like in SHa [7], a tendency to an increase in
PrPC signal was observed in the olfactory bulbs at P75.
Regional expression of PrPC
Since PrPC was not detected by immunofluorescence staining
performed following well-established protocols described in the
literature, we investigated the regional distribution of PrPC in the
Op brain at P15, P20, P37 and P70 by histoblot (see Materials
and Methods) [35]. After the completion of cortico-cerebral
neurogenesis [34], at P15 and at P20 strong PrPC immunore-
activity was detected in the hippocampus, in the thalamus and in
the neocortex. In the hippocampus, a signal was observed in the
parenchyma, but not in the pyramidal layer of the Ammon’s
Horn (CA1-CA3) nor in the granule cell layer of the dentate
gyrus (DG) (Figure 3A–B). At P37 (Figure 4A and B) a dense
PrPC signal was identified in gray matter structures such as
thalamus, cortex and hippocampus. In the latter, PrPC immu-
nostaining was deep in the stratum radiatum and in the stratum
oriens. As observed at P20, the signal was virtually absent in the
pyramidal cells of the CA and in the granule cells of the DG. In
the hilar region, immunoreactivity (IR) was minimal. IR was
observed around the dorsal and the lateral parts of the thalamus
(Figure 4A), encompassing structures involved in the communi-
cation between cortex and thalamus [38].
The PrPC signal was also evaluated at P70, after the time of
weaning [23]. A low IR was observed in white matter areas such
as the internal and external capsules (Figure 5B). As observed at
P37, in the P70 hippocampus the strongest IR was present in the
oriens and radiatum strata. A less intense signal was detected in the
stratum lacunosum-moleculare (Figure 5C). The expression pattern
profile observed in adult Op hippocampus is similar to that in
SHa [7].
PrPC immunolocalization in Mo brain coronal sections
Histoblots of P30 MoPrP+/+ brain coronal sections were
immunostained to measure differences in PrPC localization
between Op and Mo (Figure 6A and B). The lack of IR in
P30 MoPrP2/2 coronal sections (Figure 6C and D) confirmed
the specificity of the D18 signal. Ponceau staining was performed
to ensure the presence of the section on the nitrocellulose
membrane.
The pattern of PrPC distribution in P30 MoPrP+/+ was detected
in many structures throughout the brain (Figure 6A and B). At P30
strong IR was found in the alveus, a thalamo-limbic structure of
fornix fibers surrounding the stratum oriens that contains the axons
of pyramidal neurons. As previously reported [6], a well-defined
PrPC signal was present in the stratum lacunosum-moleculare
(Figure 6A). Strong labeling of the white matter fiber bundles
was particularly evident at the level of the corpus callosum – the
major interhemispheric fiber bundle in eutherians – and in the
anterior commissure, also involved in interhemispheric commu-
nication [39]. Within the limbic system, a signal was detected in
Mapping PrP Distribution in Opossum and Mouse CNS
PLOS ONE | www.plosone.org 3 November 2012 | Volume 7 | Issue 11 | e50370
the hippocampal fimbria, in its continuation, the fornix and in the
hippocampus. In the neocortex (NCx), staining was detected in a
region adjacent to the ependymal layer.
Discussion
Over the last twenty years, the expression of PrPC in the CNS of
placental mammals, such as Mo and SHa, has been intensively
investigated. Here we described a restricted PrPC expression
during Op brain development. Our data appear to corroborate
current evidence of a developmentally regulated expression of
PrPC in all mammals. The direct comparison between Op and
MoPrPC expression in CNS showed striking differences in distinct
brain regions, such as white matter structures and hippocampus,
thus suggesting possible functional implications for the role of PrPC
in marsupials.
Technical remarks about PrPC detection in Op brain
The routine histological techniques might not be sensitive
enough to map PrPC expression in the Op brain. We tested
different immunofluorescence protocols in combination with
several monoclonal antibodies, but none of them appeared to
work (data not shown). We speculated that these technical
difficulties experienced with the traditional immunohistochemical
staining techniques might be due to a weak antibody affinity for
OpPrP, possibly ascribable to epitope masking as a result of a
different membrane environment. Alternatively, PrPC signal might
be masked by another molecule, which could make the binding of
the antibody to the antigene inaccessible.
To overcome these difficulties we decided to use the
immunohistoblot technique described by Taraboulos et al. [35]
to map the regional distribution of PrPSc in the brain of diseased
Figure 2. Confirmation of antibody specificity and developmental expression of PrPC in opossum CNS. (A) Western blotting of Op,
MoPrP+/+ and MoPrP2/2 whole brain homogenates confirmed the specificity of the PrPC signal. The blot was then reprobed with b-tubulin antibody
to demonstrate equal loading of samples (50 mg per lane). (B) Western blotting analysis of equal amounts of total brain homogenate (50 mg per lane)
at different developmental stages showed a major electrophoretic band at 37 kDa, which corresponds to the diglycosylated form of the protein. b-
tubulin was used as loading control. (C) Western blotting of indicated brain regions at different developmental stages showed a relevant change in
PrPC expression during postnatal development. Each data point represents the mean absorbance 6SEM of 3 females from different litters. All the
absorbance values were normalized against b-actin.
doi:10.1371/journal.pone.0050370.g002
Figure 3. PrPC expression in histoblots of P15 and P20 opossum brains. (A–B) In coronal sections of P15 and P20 a PrPC signal was detected
in the thalamus (Th), in the neocortex (NCx) and in the hippocampus (H). The pyramidal cell layer (pyr) and the granule cell layer (gr) of the
hippocampus were not stained by PrPC (Bars: A–B 4 mm).
doi:10.1371/journal.pone.0050370.g003
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SHa. The use of 0.1 M sodium hydroxide enhanced the binding of
PrP antibodies [40] thus allowing for the detection of a clear PrPC
signal in the cryostat sections of the freshly frozen Op brain tissues
in this study.
Comparison of PrPC distribution between marsupials and
placental mammals
Our results showed that from the day of birth (P1) up to
adulthood (P75) PrPC was detectable by Western blotting in whole
brain homogenates (Figure 2B) with the strongest PrPC signal in
the uppermost diglycosylated band (,37 kDa) and the weakest
signal in the lowest non-glycosylated PrPC band (,26 kDa). A
change in PrPC relative abundance was observed during Op brain
development, corroborating previous evidence of a developmen-
tally regulated expression of PrPC. In the different brain regions
under consideration, PrPC levels either remained at plateau or
decreased slightly in adulthood (Figure 2C). Interestingly, after the
time of weaning a tendency to an increase in PrP expression was
observed in the olfactory bulbs. As postulated for placental
mammals [7] this finding might be related to ongoing plasticity of
the olfactory bulbs also in marsupials. However, no evidence is
available yet to suggest that there is indeed plasticity in the
olfactory bulbs of adult marsupials.
At P37 we observed a strong PrPC immunoreactivity in the
thalamus, a region which has a strong nonphotic influence on
sleep and circadian rhythmicity [41]. This finding suggested an
evolutionary conserved involvement of PrPC in sleep homeostasis
in the Op, in which a functioning circadian timing system exists
[42–44].
Before weaning, PrPC was detectable in the parenchyma of the
hippocampus (Figure 3B). Interestingly, in different eutherian
species, PrPC preferentially localizes in specific hippocampal
layers. In the adult Op (Figure 5C) and SHa [7] the strongest
immunoreactive strata are the oriens and the radiatum, whereas
MoPrPC specifically localizes in the stratum lacunosum-moleculare
(Figure 6A). These results seem to suggest a different regulatory
role of PrPC in the synaptic activity of different species. The lack of
PrPC in the nerve cell bodies was implied by the absence of signal
Figure 4. PrPC distribution in a P37 opossum brain. (A–B) Coronal sections in the caudal diencephalon from a P37 opossum were stained for
PrPC in the thalamus (Th) and in the parenchyma of the hippocampus. (A) In the ventral thalamus, a strong IR was observed in the reticular nucleus
(Rt) and in the nucleus reuniens (Re). No IR was observed in the optic tract (Ot). In the hypothalamic area (H) the immunoreactivity was lower than in
the thalamus. (B) A strong PrPC signal was observed in the stratum oriens (or) and in the stratum radiatum (rad) of the hippocampus. A low PrPC
immunoreactivity was observed in the hilar region (h), while the pyramidal (pyr) and granule (gr) cell layers of the CA1-CA3 and DG were devoid of
immunostaining (Bars: 1 mm).
doi:10.1371/journal.pone.0050370.g004
Figure 5. Coronal sections of opossum brain at P70 (A–C). In (A) the coronal section was Nissl-stained. In the adult opossum (B) a strong signal
was predominantly present in the hippocampus. Marginal signal was also detected in the caudate nucleus (C), in the internal capsule (iC) and in the
putamen (Pu). A very residual signal was observed in the external capsule (eC). In (C) the specific distribution of PrPC in the different hippocampal
layers was analyzed. Staining in the lacunosum and moleculare (lac/mol) was lower than in the oriens (Or) and the radiatum (Rad). PrPC
immunoreactivity was also observed in the subiculum (Sb) the main output of the hippocampus. (Bars: 0.5 mm).
doi:10.1371/journal.pone.0050370.g005
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in the pyramidal cell layer and granule cell layer of the dentate
gyrus in both Mo and Op.
The most striking difference observed between the two species
was the different localization of PrPC in the white matter. The
lower PrPC signal in Op white matter structures argues for a lower
expression of the protein by glial cells and neuronal axons. In P30
mice instead, a strong PrPC immunoreactive signal was detectable
in the corpus callosum, a specific eutherian structure enriched in
myelinated axons and involved in interhemispheric communica-
tion [45].
Implications for TSE pathology
The different ability of prions to infect certain species is
apparently encoded by their structural features, which result in
different physio-pathological outcomes [46]. Indeed some species
may result resistant to prion infection. This strain-like behavior is
known as the prion transmission barrier. However, under
controlled laboratory conditions, prions are able to adapt and
infect species previously believed to be TSE resistant, as was
recently reported in rabbits infected by the murine ME7 prion
strain using protein misfolding cyclic amplification (PMCA)
techniques [47].
Structural studies on the recombinant PrP of mammals for
which no TSEs have been reported in natural conditions [e.g.
horse, rabbit and the marsupial Tammar wallaby (Macropus
eugenii)], postulated that resistance to prions might be due to some
structural features in the globular domain of those mammalian
PrP sequences [48–50]. The OpPrP sequence presents an
outstandingly large number of amino acid substitutions at the N-
terminus in the copper binding sites and, within the C-terminus
domain, in epitopes (residues 163–174 and 221–230 in Mo
numbering, Figure 1) critical for prion conversion [22,51–54].
Based on this sequence identity analysis, it is possible to argue that
these amino acidic differences might have an impact on the ability
of OpPrP to sustain prion conversion. On the other hand, if
structural differences in mammalian PrP are important for
understanding the molecular mechanisms of TSEs, the neuronal
distribution of PrPC in mammalian species that are putatively
resistant to prion diseases should be considered.
It is noteworthy that PrPSc accumulates in the white matter
areas of Mo and SHa brains, thus suggesting that glial cells may be
the primary targets for prions [35,55]. Indeed, the infectious agent
has been shown to spread from the needle track along white
matter pathways towards the gray matter [56]. This hypothesis is
strengthened by pathological studies in human brains of terminal
CJD patients showing axonal damage, hence suggesting a
transport of prions through white matter pathways [57].
Although prion diseases have not been reported in the Op so
far, the differential expression profile might account for a different
susceptibility to prions in general or to diverse prion strains in
particular, as well as for a different pattern of PrPSc accumulation
and propagation between placentals and marsupials. To under-
stand the biological and neurological significance of our observa-
Figure 6. Localization of PrPC in P30 MoPrP+/+ brain and control of signal specificity. (A) At P30 a well-defined signal was present in the
hippocampal stratum lacunosum-moleculare layer (lac/mol) and in the alveus (alv) lying just deep to the stratum oriens layer (or). (B) In the septum-
caudatum, PrPC signal was detected predominantly in white matter fiber bundles, such as the anterior commissure (ac) and the corpus callosum (cc).
The dark dots observed in the caudate-putamen (CPu) are fiber fascicles cut on end. (C) At P30, the lack of IR in MoPrP2/2 coronal section confirmed
the signal specificity. (D) The presence of the brain section on the nitrocellulose membrane was confirmed by Ponceau staining. (Bars: A–D 0.5 mm).
doi:10.1371/journal.pone.0050370.g006
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tions, it would be of interest to attempt specific prion infectivity
experiments in this mammalian model.
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